Proteome Sciences (LON:PRM) Shares Up 16.3% – Here’s What Happened

Proteome Sciences plc (LON:PRM) shares shot up 16.3% during mid-day trading on Friday . The company traded as high as GBX 1.50 and last traded at GBX 1.50. 210,243 shares were traded during trading, a decline of 49% from the average session volume of 411,285 shares. The stock had previously closed at GBX 1.29.

Proteome Sciences Price Performance

The stock has a market capitalization of £5.26 million, a PE ratio of -1.33 and a beta of 0.07. The company has a quick ratio of 0.37, a current ratio of 0.13 and a debt-to-equity ratio of -165.46. The stock’s 50 day moving average price is GBX 1.64 and its 200-day moving average price is GBX 2.

Proteome Sciences (LON:PRM) last issued its earnings results on Wednesday, April 15th. The company reported GBX (1.04) earnings per share (EPS) for the quarter. The company had revenue of GBX 376 million for the quarter. Proteome Sciences had a negative net margin of 81.50% and a positive return on equity of 33.80%.

Proteome Sciences Company Profile

Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.